MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Gene That Causes Familial Pancreatic Cancer

Back to pancreas Blogs list Cancer blog  


Subscribe To Pancreas RSS Feed  RSS content feed What is RSS feed?

Gene That Causes Familial Pancreatic Cancer

Gene That Causes Familial Pancreatic Cancer
An international group of scientists has discovered that the mutated form of a gene called Palladin causes familial pancreas cancer. The findings, published online today (Dec. 12) in the peer-evaluated journal PLoS-Medicine, may help explain why the disease is so deadly. The research project was led by Dr. Teri Brentnall, University of Washington associate professor of medicine, and supported by The Lustgarten Foundation, Canary Foundation, and other private sources.

Pancreas cancer is commonly a fatal diagnosis. One of the deadliest types of cancer, it is the fourth leading cause of cancer deaths overall, and third-leading cause of cancer deaths for people aged 40 to 60 in the United States. Most people with the disease die within a year of diagnosis; about 95 percent of patients die within five years. Scientists estimate that at least ten percent of all pancreas cancer cases are inherited.

The discovery also reveals that the Palladin gene behaves abnormally in both the hereditary and non-hereditary, or sporadic, forms of pancreas cancer. Prior studies by co-author Dr. Carol Otey, associate professor of physiology at the University of North Carolina, have revealed that when the Palladin gene is functioning properly, it gives a cell its shape and enables the cell to move. In the case of pancreas cancer, a mutation in Palladin allows the cell to move much more quickly than normal, essentially invading the surrounding, healthy tissue.

Palladin, identified six years ago by Otey, is involved in the cytoskeleton, the structural backbone of all human cells. Brentnall discovered that Palladin played a role in pancreas cancer and began to collaborate with Otey. The team believes that the mutated Palladin causes cancer by causing the cytoskeleton to malfunction, which allowed the cells to move much more quickly than normal cells.

"A normal cytoskeleton holds up the cell wall, and gives it direction to sit down in its proper place and basically to behave," said Brentnall. "In malignant cells, the cytoskeleton doesn't work correctly, and instead of sitting, the cells get up and invade areas where they don't belong, which is how the cancer spreads. This is a new way of thinking about cancer development in the pancreas."

"Brentnall and her colleagues' report of their fascinating discovery of a new cause of inherited pancreas cancer provides us with important new insights into the mechanisms of pancreas cancer development that will have a significant impact on future research," said Michael Goggins, MD, Associate Professor of Pathology, Medicine and Oncology at The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins.

Brentnall began her search for the pancreas cancer gene in 1996 when one of her patients described his family's "curse." His grandfather, father, four uncles and three cousins had all died of pancreas cancer, some at a very young age. Brentnall designated this family as "Family X" and set off to identify the source of the fatal inheritance. The puzzle took a decade to unravel.

Brentnall and her colleagues developed a surveillance program for the early detection of pancreatic pre-cancer in families who inherit the disease. "By performing surveillance on a number of of the Family X members, the research team identified which ones had the initial stages of pancreas cancer" said Brentnall. "We then compared DNA samples from the family members with pre-cancer to those who did not have the disease, and isolated the cancer-causing gene to an area of Chromosome 4."

Over the next two years, the researchers, led by Dr. Kay Pogue-Geile, associate professor of research at University of Pittsburgh School of Medicine, created a customized DNA microarray to help them isolate the gene responsible. They searched for the genes most abnormally expressed in that area on Chromosome 4, using pre-malignant tissue from Family X pancreas and from 10 sporadic pancreas cancers, comparing the results to normal pancreas tissue. The researchers hoped this approach would help them find the genes that were over-expressed in abnormal pre-malignant and malignant tissue.

"We finally found what we had so doggedly pursued -- a gene that was expressed 21 times more than any other," said Brentnall. "This gene, Palladin, was mutated in Family X and appeared to cause the fatal inheritance. Every one of the members of Family X who had the Palladin mutation got pancreas cancer or pre-cancer, while the members of Family X who did not have the mutation were cancer-free."

By understanding the genes that cause pancreas cancer in families, researchers can better understand why the disease forms sporadically in the general population. When Brentnall and her colleagues examined pancreas cells from cancer patients with no family history, they observed that Palladin was also over-expressed in those cells. In fact, they observed that in these non-hereditary cases, the gene became increasingly over-expressed as the pancreas tissue progressed through the pre-cancer stage and then to cancer.

Testing for a Palladin gene mutation may be possible in families that inherit pancreas cancer (two or more affected family members). However, genetic testing is not likely to be useful for non-hereditary or sporadic pancreas cancer (only one person affected in a family). Brentnall and her team hope to develop a screening blood test for pancreas cancer using the Palladin protein, as well as therapys that target mutations in Palladin.

In addition, early indications show that the study of Palladin may also shed light on how and why other cancers spread as well. Further information regarding genetic testing can be obtained at http://www.uwgi.org/.


Posted by: Sue    Source




Did you know?
An international group of scientists has discovered that the mutated form of a gene called Palladin causes familial pancreas cancer. The findings, published online today (Dec. 12) in the peer-evaluated journal PLoS-Medicine, may help explain why the disease is so deadly. The research project was led by Dr. Teri Brentnall, University of Washington associate professor of medicine, and supported by The Lustgarten Foundation, Canary Foundation, and other private sources.

Medicineworld.org: Gene That Causes Familial Pancreatic Cancer

Advances in pancreatic cancer treatment| Detailed information on pancreatic cancer| Pancreas cancer main| Major topics in pancreatic cancer| Overview of pancreatic cancer| Pancreatic cancer resources| More resources for pancreatic cancer| Resources 3 for pancreatic cancer| Resources4 for pancreatic cancer| Resources5 for pancreatic cancer| Resources6 for pancreatic cancer| Resources7 for pancreatic cancer| Resources8 for pancreatic cancer|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.